Variant report
Variant | nsv984066 |
---|---|
Chromosome Location | chr15:45847550-45849255 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:9)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:6)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:9 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BCL11A | chr15:45848437-45848748 | GM12878 | blood: | n/a | n/a |
2 | CHD2 | chr15:45848464-45848760 | GM12878 | blood: | n/a | n/a |
3 | EP300 | chr15:45848438-45848757 | GM12878 | blood: | n/a | n/a |
4 | EP300 | chr15:45848529-45848708 | GM12878 | blood: | n/a | n/a |
5 | EP300 | chr15:45848327-45848774 | GM12878 | blood: | n/a | n/a |
6 | SPI1 | chr15:45848268-45849108 | GM12878 | blood: | n/a | n/a |
7 | SPI1 | chr15:45848341-45848822 | GM12891 | blood: | n/a | n/a |
8 | SPI1 | chr15:45848407-45848793 | GM12878 | blood: | n/a | n/a |
9 | SPI1 | chr15:45848434-45848786 | GM12891 | blood: | n/a | n/a |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr15:45842433..45843997-chr15:45848570..45850366,2 | K562 | blood: |
(count:6 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-C15orf48-1 | chr15:45847688-45848928 | NONHSAT042265 |
2 | lnc-C15orf48-1 | chr15:45847671-45848098 | NONHSAT042270 |
3 | lnc-C15orf48-1 | chr15:45847671-45848300 | NONHSAT042267 |
4 | lnc-C15orf48-1 | chr15:45847688-45848300 | NONHSAT042266 |
5 | lnc-C15orf48-1 | chr15:45847671-45848928 | NONHSAT042264 |
6 | lnc-C15orf48-1 | chr15:45847680-45848169 | NONHSAT042272 |
No data |
No data |
Variant related genes | Relation type |
---|---|
HMGN2P46 | TF binding region |
ENSG00000259681 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs371003928 | chr15:45847729-45847730 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs150737821 | chr15:45847748-45847749 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs558283558 | chr15:45847785-45847786 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs537876887 | chr15:45847787-45847788 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs181267621 | chr15:45847788-45847789 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs367923687 | chr15:45847794-45847795 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs370261780 | chr15:45847802-45847803 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs368608729 | chr15:45847803-45847804 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs543761748 | chr15:45847806-45847807 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs372742223 | chr15:45847813-45847814 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
11 | rs368369764 | chr15:45847814-45847815 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
12 | rs147816560 | chr15:45847819-45847820 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
13 | rs183934743 | chr15:45847824-45847825 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
14 | rs139112818 | chr15:45847828-45847829 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
15 | rs143982485 | chr15:45847839-45847840 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
16 | rs559455607 | chr15:45847851-45847852 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
17 | rs8042811 | chr15:45847921-45847922 | Enhancers | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
18 | rs551725560 | chr15:45847934-45847935 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs370049856 | chr15:45847939-45847940 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs139971473 | chr15:45847960-45847961 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs565687291 | chr15:45847971-45847972 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs565141366 | chr15:45847975-45847976 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs369397044 | chr15:45847976-45847977 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs530795698 | chr15:45847985-45847986 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs149729248 | chr15:45847990-45847991 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs372593860 | chr15:45847991-45847992 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs530631212 | chr15:45848014-45848015 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs145569115 | chr15:45848023-45848024 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs148863468 | chr15:45848093-45848094 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs143720304 | chr15:45848101-45848102 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs188225754 | chr15:45848124-45848125 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs147684411 | chr15:45848134-45848135 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs142365057 | chr15:45848136-45848137 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs376148744 | chr15:45848142-45848143 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs12440560 | chr15:45848153-45848154 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs112508795 | chr15:45848158-45848159 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs566538255 | chr15:45848195-45848196 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs372861121 | chr15:45848231-45848232 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs538759527 | chr15:45848275-45848276 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs182226902 | chr15:45848290-45848291 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs56383432 | chr15:45848323-45848324 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs376676510 | chr15:45848330-45848331 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs545043298 | chr15:45848360-45848361 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs376517831 | chr15:45848366-45848367 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs575140259 | chr15:45848437-45848438 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs74494841 | chr15:45848509-45848510 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs187245296 | chr15:45848634-45848635 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs191619025 | chr15:45848676-45848677 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs542780374 | chr15:45848717-45848718 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs559545342 | chr15:45848740-45848741 | Enhancers | TF binding regionlncRNA | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Schizophrenia | 19415332 | CNVD |
Breast cancer | 22522925 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
cataract | 16735990 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Medulloblastoma | 21979893 | CNVD |
spastic paraplegia with thinning of corpus callosum | 19105190 | CNVD |
Schizophrenia | 21324950 | CNVD |
Astrocytoma | 17387387 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Disease | 21824424 | CNVD |
Melanoma | 18172304 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Gastric cancer | 17167181 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Intellectual disability | 22102821 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Prostate cancer | 16573809 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21785460 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 18632612 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Cancer | 21129771 | CNVD |
Papillary thyroid carcinoma | 22161024 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 21045282 | CNVD |
Breast cancer | 22032731 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Abnormal phenotypes | 18644119 | CNVD |
Cancer | 16751803 | CNVD |
Melanoma | 17363583 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Marfan syndrome | 17492313 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr15:45847800-45849200 | Enhancers | GM12878-XiMat | blood |
2 | chr15:45848000-45849200 | Enhancers | Primary monocytes fromperipheralblood | blood |
3 | chr15:45848200-45848600 | Enhancers | Primary B cells from cord blood | blood |
4 | chr15:45848200-45849200 | Enhancers | Monocytes-CD14+_RO01746 | blood |
5 | chr15:45848400-45849200 | Enhancers | Primary B cells from peripheral blood | blood |
6 | chr15:45849200-45850200 | Weak transcription | Primary B cells from peripheral blood | blood |